Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04599504 · ClinicalTrials.gov registry record · Phase 2
Pharmacological and Behavioral Treatment After Bariatric Surgery: Medication Change for Non-Responders (Stage 2b)
A Phase 2 study of Loss-of-control Eating and Obesity/Overweight, sponsored by Yale University.
- Active
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT04599504 is a Phase 2 study of Loss-of-control Eating and Obesity/Overweight that is active but no longer recruiting, run by Yale University. The registered enrollment target is 60 participants, below the 89-participant average among 3 other Loss-of-control Eating trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04599504, a Phase 2 study of Loss-of-control Eating and Obesity/Overweight, is active but no longer recruiting, sponsored by Yale University.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test the effectiveness of lisdexamfetamine medication as a treatment for loss-of-control eating and weight following bariatric surgery. This is a controlled test of whether, amongst non-responders to acute treatments, lisdexamfetamine medication results in superior outcomes compared with placebo.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Lisdexamfetamine Dimesylate (Medication)
Study Locations (1)
Connecticut
- Yale School of Medicine - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-01-02 |
| Est. Completion | 2027-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04599504
The ClinicalTrials.gov registry entry for NCT04599504 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 89-participant average among 3 other Loss-of-control Eating trials with a reported enrollment target (33% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Loss-of-control Eating appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04599504 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT04599504 about?
NCT04599504 is a clinical study titled "Pharmacological and Behavioral Treatment After Bariatric Surgery: Medication Change for Non-Responders (Stage 2b)". This study will test the effectiveness of lisdexamfetamine medication as a treatment for loss-of-control eating and weight following bariatric surgery. This is a controlled test of whether, amongst non-responders to acute treatments, lisdexamfetamine medication results in superior outcomes compared ...
What is the current status of trial NCT04599504?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2022-01-02. Estimated completion is 2027-05.
What conditions does trial NCT04599504 study?
This clinical trial studies the following conditions: Loss-of-control Eating, Obesity/Overweight.
What interventions are being tested in trial NCT04599504?
The interventions under investigation include: Placebo (OTHER), Lisdexamfetamine Dimesylate (Medication) (DRUG).
Who is sponsoring clinical trial NCT04599504?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04599504 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Loss-of-control Eating
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)
RECRUITING · Phase 2
-
Pharmacological and Behavioral Treatments After Bariatric Surgery: Maintenance Treatment (Stage 2a)
ACTIVE NOT RECRUITING · Phase 2
-
Responsive Neurostimulation For Loss Of Control Eating
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.